Synaptic reports on Big Pharma's billion-dollar bets on AI-designed drugs
Eli Lilly, Novartis, J&J partnered with Isomorphic Labs; GSK licensed Noetik's cancer models; AstraZeneca acquired Modella AI; Lilly launched AI initiative with NVIDIA.
See the latest news and media coverage for Synaptic. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-powered deal sourcing platform for investors
synaptic.comLast updated
In short: Synaptic showcased its market-intelligence leadership by mapping AI startup sectors, while Synaptics reported a fiscal loss and launched new chips.
Eli Lilly, Novartis, J&J partnered with Isomorphic Labs; GSK licensed Noetik's cancer models; AstraZeneca acquired Modella AI; Lilly launched AI initiative with NVIDIA.
It lists recent incidents and emerging security tools across six layers from 75+ startups. Access the full list via link.
It provides a single view of portfolio companies, tracking investment performance, metrics, ownership, and internal notes for teams.
The post announces the arrival of physical intelligence, listing startups across six layers of the stack with funding data. It highlights $14B raised in 2025.
Value Investing- Start investing with zero membership cost and gain access to high-upside stock opportunities, market intelligence, and expert trading commentary. Synaptics Incorporated (SYNA ...
Earlier this month, Synaptics announced it will showcase its AI-native Astra embedded compute...
Synaptics (NASDAQ:SYNA) reported its sixth consecutive quarter of double-digit year-over-year revenue growth in the third quarter of fiscal 2026, with...
Synaptics CEO Rahul Patel sells $205,290 in company stock...
Track Synaptic and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Synaptic and other trending companies.